Jennewein takes on Nestlé over baby formula patents

German biotech Jennewein has accused Nestlé Nutrition of infringing patents covering a process of purifying human milk oligosaccharides (HMOs) to make its infant formula.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Sports nutrition company sues NASCAR driver over TMs

23 April 2020 NASCAR driver Caesar Bacarella’s sports clothing line and supplement business have been hit with a lawsuit by an Australia company.

Americas

Nestlé Skin Health has face injection infringement claims thrown out

17 December 2019 Nestlé Skin Health will not face claims that it misappropriated trade secrets related to a training platform for teaching medical professionals how to perform facial injections, a US court has ruled.

Americas

Nestlé health unit sued over injection technology

15 October 2018 Nestlé’s Skin Health unit has been accused of infringing patents and misappropriating trade secrets relating to neurotoxin and derma filler injections.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Jennewein takes on Nestlé over baby formula patents

More on this story

Editor's picks

Editor's picks

More features